CLDX vs HUBB · rev $37.0K vs P/E 28, rev $5.84B
Celldex Therapeutics Inc (CLDX) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
CLDX currently screens at market cap $2.35B. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the CLDX and HUBB stock pages for the full models.
Not investment advice.